UAE Periodontal Therapeutics Market Analysis

UAE Periodontal Therapeutics Market Executive Summary

UAE Periodontal Therapeutics Market is at around $4.4 Mn in 2023 and is projected to reach $7.6 Mn in 2030, exhibiting a CAGR of 8.2% during the forecast period.

Periodontal diseases affect the gums, periodontal ligaments, and alveolar bone, which support and surround the teeth. Bacterial infections causing periodontal illnesses including gingivitis and periodontitis are characterized by inflammation, bleeding gums, loss of bone, and tooth loss. The main causes of periodontal problems are smoking, hormonal changes, poor oral care, and a few genetic factors. As an adjuvant therapy for periodontal diseases, antibiotics are frequently utilized to reduce bacterial infections. Metronidazole, amoxicillin, and doxycycline are often used antibiotics in periodontal therapy. Adjunctive therapies for reducing gingival inflammation and plaque include a variety of mouthwashes and rinses that contain antimicrobial agents such as hydrogen peroxide, chlorhexidine, and essential oils.

The UAE periodontal market, with a prevalence rate of 24%, is significantly influenced by various demographic factors. The high prevalence is primarily observed among adults aged 30-50 years, with a higher incidence in males compared to females. Urbanization, lifestyle changes, and dietary habits contribute to this trend. Healthcare expenses in this sector are substantial, with costs driven by advanced treatments and the need for specialized dental care. Efforts to improve public awareness and access to preventive care are critical to addressing the rising demand for periodontal services in the UAE. Therefore, the market is driven by significant factors like Rising Geriatric Population, Government Support and Initiative, and Advancements in Treatment Technologies. However, Side Effects, Healthcare Workforce Limitations, and High Costs restrict the growth and potential of the market.

Ultradent Products Inc is known to develop, manufacture, and market dental materials and equipment. Its product portfolio entails tooth whitening products, crown and bridge, endodontic instruments, tissue management products, bond and etch products, and more.

Market Dynamics

Market Growth Drivers

Rising Geriatric Population: UAE is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 – 2050. Geriatric patients present unique challenges in periodontal care, fueling market growth. Studies show that the demand for periodontal care among the elderly is expected to rise by 40% over the next decade, underscoring the growing need for tailored treatments in this demographic.

Government Support and Initiative: Government support through policies aimed at enhancing oral healthcare services and regulations promoting dental hygiene standards play a significant role in shaping the periodontal therapeutics market. Recent data indicates that countries with robust dental hygiene standards experience a 20% increase in patient trust and engagement with periodontal therapies, highlighting the positive impact of regulatory support on market dynamics.

Advancements in Treatment Technologies: In order to better understand your individual needs, dentists can now develop 3D images of your mouth using modern imaging technology. Treatment planning, such as implant placement, is substantially more accurate with the use of these comprehensive photographs. Digital scans will make your visits more comfortable as they will replace messy impressions. Your dentist can more clearly explain treatments and show you exactly what's happening in your mouth.

Market Restraints

Side Effects: UAE faces challenges related to the side effects of antibiotic therapies commonly prescribed in periodontal treatment. Issues such as antibiotic resistance and gastrointestinal disturbances may lead to patient reluctance or non-compliance with prescribed treatment regimens.

Healthcare Workforce Limitations: There is a shortage of specialized periodontal healthcare professionals in the UAE. While the country has made significant investments in its healthcare infrastructure, attracting and retaining qualified periodontists and dental specialists remains a challenge. Currently, only 30% of dental clinics in the UAE have access to specialized periodontal care due to workforce shortages, highlighting the critical need for more qualified professionals in this field.

High cost: The high cost of living and imported medical supplies contribute to the elevated prices of periodontal procedures. Additionally, private healthcare dominates the sector, leading to significant out-of-pocket expenses for patients. In fact, over 60% of residents and expatriates in the UAE face financial barriers that limit their access to comprehensive periodontal care, highlighting the significant impact of cost on market accessibility and growth.

Regulatory Landscape and Reimbursement scenario

The regulatory landscape for the periodontics market in the UAE is shaped by stringent guidelines set forth by the Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA). These bodies enforce strict licensure requirements for dental practitioners and clinics, ensuring adherence to high standards of care. Regulations focus on quality control, patient safety, and the implementation of advanced dental technologies. The market is also influenced by continuous professional development mandates, encouraging practitioners to stay updated with the latest periodontal treatments and procedures, thus maintaining a competitive and globally aligned healthcare environment.

In UAE, reimbursement policies vary significantly depending on insurance providers and the specific treatments required. Typically, basic periodontal treatments, such as scaling and root planning, may be covered partially or fully by standard health insurance plans. However, more advanced procedures like periodontal surgery or regenerative treatments often require additional coverage or are subject to higher co-pays and deductibles. Dental insurance policies in the UAE are generally less comprehensive compared to medical insurance, necessitating out-of-pocket payments for many periodontal services. Patients are advised to review their insurance terms closely to understand the extent of coverage and potential costs.

Competitive Landscape

Key Players

Here are some of the major key players in the UAE Periodontal Therapeutics Market:

• 3M Company UAE
• Zimmer Biomet UAE
• Dentsply Sirona UAE
• Planmeca UAE
• Pfizer Inc.
• Lupin Ltd
• Teva Pharmaceuticals USA, Inc.
• Sun Pharmaceutical Industries Ltd.
• Tokyo Chemical Industry Co., Ltd.
• Bausch Health Companies Inc.
• Melinta Therapeutics LLC
• Cipla, Inc.
• Chartwell Pharmaceuticals LLC.
• ASA Dental S.p.A.
• Steris-Hu-Friedy
• Carl Martin GmBH